Fremanezumab in Children and Adolescents with Episodic Migraine

Original Article

A.D. Hershey, C.L. Szperka, P. Barbanti, P. Pozo-Rosich, P. Bittigau, S. Barash, J. Bryson, Y. Kessler, Y.C. Schwartz, V.R. Campos, and X. Ning

N Engl J Med 2026;394:243-252

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
01/14/2026
Course expires: 
01/15/2028

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.